Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Keunwha Pharmaceutical Co Ltd Appoints New CEO


Tuesday, 2 Apr 2013 07:51pm EDT 

Keunwha Pharmaceutical Co Ltd announced that it has appointed Lee Ju Hyeong as its new Chief Executive Officer, replacing Peter Keil, effective April 22, 2013. 

Company Quote

22050.0
2850.0 +14.84%
1:19am EDT